CSPC Pharma to Present Updates from Eight Trials at European Oncology Conference
MT Newswires Live
Yesterday
CSPC Pharmaceutical Group (HKG:1093) will present the latest updates from eight clinical trials at the European Society for Medical Oncology (ESMO) Congress, two of which have been selected as late-breaking abstracts.
The updates will be presented at the conference, to be held in Madrid, Spain, from Oct. 23 to Oct. 27, as one proffered paper, three rapid oral, three poster, and one e-poster presentation, a Monday bourse filing showed.
The updates will cover a broad range of oncology types such as breast, lung, gastric, liver, colorectal, and pancreatic cancers.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.